UPDATE 1-FDA warns of severe joint pain risk with DPP-4 diabetes drugs
August 28, 2015 at 16:23 PM EDT
Aug 28 (Reuters) - A class of diabetes drugs that include Merck & Co Inc's Januvia has been linked with severe joint pain, the U.S. Food and Drug Administration said on Friday.
